Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Yang XuDivision of CryoEM and Bioimaging, Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Stanford University, Menlo Park, CA, USA.
Rose Marie Haynes YasudaPacific Northwest Center for Cryo-Electron Microscopy, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-7382-3169
Joshua A NasburgDepartment of Pharmacology, School of Medicine, University of California Davis, Davis, CA, USA.
Meng CuiDepartment of Pharmaceutical Sciences and Center for Drug Discovery, School of Pharmacy and Pharmaceutical Sciences, Bouvé College of Health Sciences, Northeastern University, Boston, MA, USA.ORCID http://orcid.org/0000-0002-3895-135X
K George ChandyLKCMedicine-ICE Collaborative Platform, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Heike WulffDepartment of Pharmacology, School of Medicine, University of California Davis, Davis, CA, USA.
Miao ZhangDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, CA, USA. miaozhangphd@arizona.edu.ORCID http://orcid.org/0000-0002-3099-155X
Funding
The Stanford-SLAC CryoEM Center supplementU24GM129541 · NIGMS · STANFORD UNIVERSITY · PI CHIU, WAH, HEDMAN, BRITT · 2018 to 2023
$54.8M
Pacific Northwest Center for Cryo-EM: Equipment SupplementR24GM154185 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI James E Evans, CLAUDIA SUSANA LOPEZ · 2024 to 2026
$21.5M
Molecular mechanism for pharmacological activation of KCa2 channelsR01NS145389 · NINDS · UNIVERSITY OF ARIZONA · PI HEIKE WULFF, Miao Zhang · 2025 to 2026
$1.2M
Development of SK channel modulators as therapeutic agents for ataxiaR33NS101182 · NINDS · CHAPMAN UNIVERSITY · PI BEZPROZVANNY, ILYA B, ZHANG, MIAO · 2021 to 2021
$723k
Channelopathy of KCa2.3 and Zimmermann-Laband syndromeR15NS130420 · NINDS · CHAPMAN UNIVERSITY · PI ZHANG, MIAO · 2024 to 2024
$434k
American Heart Association (American Heart Association, Inc.) 24CDA1260237NIGMS NIH HHS R24 GM154185NIGMS NIH HHS U24 GM129541NINDS NIH HHS R01 NS145389NINDS NIH HHS R15 NS130420NINDS NIH HHS R33 NS101182U.S. Department of Defense (United States Department of Defense) W81XWH-22-2-0081U.S. Department of Health & Human Services | National Institutes of Health (NIH) 1R01NS145389-01U.S. Department of Health & Human Services | NIH | Center for Information Technology (Center for Information Technology, National Institutes of Health) 1R15NS130420U.S. Department of Health & Human Services | NIH | Center for Information Technology (Center for Information Technology, National Institutes of Health) 4R33NS101182-03
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Structural basis for the subtype-selectivity of K · full record | OpenQuestion